Suchergebnisse - "Kelley, R K"

PubPharm (16)

11

451 Correlative and updated clinical endpoint analysis of a multicenter phase II trial of selumetinib (AZD6244) plus erlotinib in chemotherapy-refractory advanced pancreatic adenocarcinoma (PDAC)

enthalten in: The European journal of cancer / A | 2014

von Ko, A. | Tempero, A. | Bekaii-Saab, T. | +11

12

O126 EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD

enthalten in: Journal of hepatology | 2014

von Giannelli, G. | Faivre, S. | Santoro, A. | +16

13

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

enthalten in: British journal of cancer | 2013

von Kelley, R. | Hwang, J. | Magbanua, M. | +15

14

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

enthalten in: The British journal of cancer | 2013

von Kelley, R. | Hwang, J. | Magbanua, M. | +15

15

Temsirolimus combined with sorafenib in hepatocellular carcinoma : a phase I dose-finding trial with pharmacokinetic and biomarker correlates

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Kelley, R. | Nimeiri, H. | Munster, P. | +15

16

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates

enthalten in: Annals of oncology | 2013

von Kelley, R. | Nimeiri, H. | Munster, P. | +15